93 related articles for article (PubMed ID: 16362381)
1. [On the uncertainty of measurements illustrated by the BONN Risk Index].
Laube N; Kleinen L
Urologe A; 2006 Feb; 45(2):189-94. PubMed ID: 16362381
[TBL] [Abstract][Full Text] [Related]
2. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
[TBL] [Abstract][Full Text] [Related]
3. The relation of urinary Tamm-Horsfall-protein on CaOx-crystallization under the scope of the Bonn-Risk-Index.
Laube N; Glatz S; Hesse A
Urol Res; 2001 Feb; 29(1):45-9. PubMed ID: 11310215
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous urinary calcium oxalate crystallization in hypercalciuric children.
Porowski T; Konstantynowicz J; Zoch-Zwierz W; Kirejczyk JK; Taranta-Janusz K; Korzeniecka-Kozerska A
Pediatr Nephrol; 2009 Sep; 24(9):1705-10. PubMed ID: 19350280
[TBL] [Abstract][Full Text] [Related]
5. Can the Bonn Risk Index be replaced by a simple measurement of the urinary concentration of free calcium ions?
Laube N; Hergarten S
J Urol; 2005 Jun; 173(6):2175-7. PubMed ID: 15879882
[TBL] [Abstract][Full Text] [Related]
6. [Monitoring of the treatment of calcium-oxalate stone formers with the Bonn-Risk-Index].
Laube N; Schmidt M; Hesse A
Urologe A; 2003 Feb; 42(2):243-9. PubMed ID: 12607094
[TBL] [Abstract][Full Text] [Related]
7. Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children.
Porowski T; Zoch-Zwierz W; Wasilewska A; Spotyk A; Konstantynowicz J
Pediatr Nephrol; 2007 Apr; 22(4):514-20. PubMed ID: 17216257
[TBL] [Abstract][Full Text] [Related]
8. Problems in the investigation of urine from patients suffering from primary hyperoxaluria type 1.
Laube N; Hoppe B; Hesse A
Urol Res; 2005 Nov; 33(5):394-7. PubMed ID: 16151774
[TBL] [Abstract][Full Text] [Related]
9. Analytical precision of the Urolizer for the determination of the BONN-Risk-Index (BRI) for calcium oxalate urolithiasis and evaluation of the influence of 24-h urine storage at moderate temperatures on BRI.
Berg W; Bechler R; Laube N
Clin Chem Lab Med; 2009; 47(4):478-82. PubMed ID: 19222375
[TBL] [Abstract][Full Text] [Related]
10. The influence of freezer storage of urine samples on the BONN-Risk-Index for calcium oxalate crystallization.
Laube N; Zimmermann DJ
Clin Chem Lab Med; 2004; 42(6):665-9. PubMed ID: 15259384
[TBL] [Abstract][Full Text] [Related]
11. Bonn Risk Index based micromethod for assessing risk of urinary calcium oxalate stone formation.
Porowski T; Mrozek P; Sidun J; Zoch-Zwierz W; Konstantynowicz J; Kirejczyk JK; Motkowski R; Laube N
J Urol; 2010 Mar; 183(3):1157-62. PubMed ID: 20096860
[TBL] [Abstract][Full Text] [Related]
12. [New diagnostic tool for individual monitoring of urolithiasis risk and other metabolic diseases].
Laube N; Klein F; Bernsmann F; Fisang C
Dtsch Med Wochenschr; 2014 Aug; 139(34-35):1721-5. PubMed ID: 25116022
[TBL] [Abstract][Full Text] [Related]
13. Comparison of laser-probe and photometric determination of the urinary crystallization risk of calcium oxalate.
Laube N; Hergarten S; Hesse A
Clin Chem Lab Med; 2002 Jun; 40(6):595-9. PubMed ID: 12211654
[TBL] [Abstract][Full Text] [Related]
14. [Extended metabolic diagnosis of urolithiasis].
Laube N; Bradenahl J; Thomas E; Meissner A; Müller SC
Aktuelle Urol; 2006 Nov; 37(6):436-42; quiz 423-4. PubMed ID: 17099832
[TBL] [Abstract][Full Text] [Related]
15. Testing the predictability of the relative urinary supersaturation from the Bonn-Risk-Index for calcium oxalate stone formation.
Laube N; Hergarten S; Hesse A
Clin Chem Lab Med; 2001 Oct; 39(10):966-9. PubMed ID: 11758612
[TBL] [Abstract][Full Text] [Related]
16. Calcium oxalate stone formation risk - a case of disturbed relative concentrations of urinary components.
Laube N; Rodgers A; Allie-Hamdulay S; Straub M
Clin Chem Lab Med; 2008; 46(8):1134-9. PubMed ID: 18578688
[TBL] [Abstract][Full Text] [Related]
17. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
Kavanagh JP; Laube N
J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047
[TBL] [Abstract][Full Text] [Related]
18. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
Conte A; Pizá P; García-Raja A
Arch Esp Urol; 1999; 52(1):94-9. PubMed ID: 10101897
[TBL] [Abstract][Full Text] [Related]
19. Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats.
Li Y; McMartin KE
Am J Physiol Renal Physiol; 2009 May; 296(5):F1080-7. PubMed ID: 19244400
[TBL] [Abstract][Full Text] [Related]
20. Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion.
Ferraz RR; Tiselius HG; Heilberg IP
Kidney Int; 2004 Aug; 66(2):676-82. PubMed ID: 15253722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
